GMP Platform

Latest Article

2024/12/19 AD

PMDA ORANGE LETTER_2024.9

2024/11/25 AD

PMDA ORANGE LETTER_2024.6

2024/10/17 AD

PMDA ORANGE LETTER_2024.3

2024/09/24 AD Regulation-related Trends/Others

Regulation of Nitrosamine Impurities in Pharmaceutical Products

Regulation of Nitrosamine Impurities in Pharmaceutical Products

2024/09/05 AD Regulation-related Trends/Others

Subjectivity and Formality in Quality Risk Management

2024/08/15 AD Others

Microorganisms, too embarrassed to ask others about！（Part 15）

2024/07/17 AD

PMDA ORANGE LETTER_2024.1

2024/07/04 AD Regulation

Drug Master File system of China （Part 2）

More Less

Recommended Articles

2024/07/04 AD Regulation

Drug Master File system of China （Part 2）

2024/09/05 AD Regulation-related Trends/Others

Subjectivity and Formality in Quality Risk Management

2024/09/24 AD Regulation-related Trends/Others

Regulation of Nitrosamine Impurities in Pharmaceutical Products

Regulation of Nitrosamine Impurities in Pharmaceutical Products

2024/08/15 AD Others

Microorganisms, too embarrassed to ask others about！（Part 15）

More Less

Editors' Picks

Search by Keywords

What's New

More Less

Our Services

You will be navigated to the CM Plus company website.

Related Sites

CM Plus Group Website

This website uses cookies to offer a better browsing experience. By clicking "Accept," you agree to use cookies for the purpose detailed in our privacy policy.